Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of THB 4.64 trillion. The enterprise value is 6.23 trillion.

Market Cap	4.64T
Enterprise Value	6.23T

Important Dates

The last earnings date was Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	Jul 25, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.92%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 13.24 and the forward PE ratio is 9.03.

PE Ratio	13.24
Forward PE	9.03
PS Ratio	2.23
PB Ratio	1.60
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.43, with an EV/FCF ratio of 15.39.

EV / Earnings	17.80
EV / Sales	3.01
EV / EBITDA	7.43
EV / EBIT	10.73
EV / FCF	15.39

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.70.

Current Ratio	1.16
Quick Ratio	0.78
Debt / Equity	0.70
Debt / EBITDA	2.42
Debt / FCF	4.99
Interest Coverage	6.26

Financial Efficiency

Return on equity (ROE) is 12.17% and return on invested capital (ROIC) is 7.18%.

Return on Equity (ROE)	12.17%
Return on Assets (ROA)	5.25%
Return on Invested Capital (ROIC)	7.18%
Return on Capital Employed (ROCE)	10.53%
Revenue Per Employee	25.67M
Profits Per Employee	4.32M
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.45

Taxes

Income Tax	-7.66B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	15.97
200-Day Moving Average	n/a
Relative Strength Index (RSI)	58.05
Average Volume (20 Days)	102,891

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.61

Income Statement

In the last 12 months, Pfizer had revenue of THB 2.08 trillion and earned 350.29 billion in profits. Earnings per share was 61.71.

Revenue	2.08T
Gross Profit	1.54T
Operating Income	577.79B
Pretax Income	343.15B
Net Income	350.29B
EBITDA	798.38B
EBIT	577.79B
Earnings Per Share (EPS)	61.71

Full Income Statement

Balance Sheet

The company has 431.64 billion in cash and 2.02 trillion in debt, giving a net cash position of -1,589.69 billion.

Cash & Cash Equivalents	431.64B
Total Debt	2.02T
Net Cash	-1,589.69B
Net Cash Per Share	n/a
Equity (Book Value)	2.90T
Book Value Per Share	508.28
Working Capital	194.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 494.81 billion and capital expenditures -89.59 billion, giving a free cash flow of 405.22 billion.

Operating Cash Flow	494.81B
Capital Expenditures	-89.59B
Free Cash Flow	405.22B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 73.82%, with operating and profit margins of 27.78% and 16.84%.

Gross Margin	73.82%
Operating Margin	27.78%
Pretax Margin	16.50%
Profit Margin	16.84%
EBITDA Margin	38.39%
EBIT Margin	27.78%
FCF Margin	19.49%

Dividends & Yields

This stock pays an annual dividend of 0.24, which amounts to a dividend yield of 1.49%.

Dividend Per Share	0.24
Dividend Yield	1.49%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	89.68%
Buyback Yield	-0.92%
Shareholder Yield	0.57%
Earnings Yield	7.55%
FCF Yield	8.74%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	8